Literature DB >> 18582635

Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit.

Mark A Scheurer1, Joshua W Salvin, Vladimiro L Vida, Francis Fynn-Thompson, Emile A Bacha, Frank A Pigula, John E Mayer, Pedro J del Nido, David L Wessel, Peter C Laussen, Ravi R Thiagarajan.   

Abstract

OBJECTIVES: We sought to determine whether the type of shunt used at stage one palliation (S1P) affected the survival and the perioperative course through Fontan completion.
BACKGROUND: Although improved surgical and interstage survival have been demonstrated with the use of the right ventricle to pulmonary artery (RV-PA) conduit compared with a modified Blalock-Taussig shunt (BTS) at S1P, it is unknown whether this effect will be observed in long-term follow-up.
METHODS: All patients who underwent a S1P during 2002 and 2003 (n = 80) at our institution were included for analysis. Patients were followed until death or June 1, 2007. Perioperative variables at Fontan completion were recorded.
RESULTS: For the entire cohort, cumulative survival for those who underwent a RV-PA conduit (n = 34) was 79.4% at 3 years compared with 65.8% in the modified BTS group (n = 46) (log-rank = 0.31). At Fontan (n = 44), when compared with those who had received a modified BTS, those who had a RV-PA conduit placed at S1P had no difference in the median duration of ventilation (21 h [range 10 to 96 h] vs. 26.5 h [range 7 to 204 h], p = 0.09) or hospital stay (9 days [range 5 to 29 days] vs. 10 days [range 6 to 48 days], p = 0.89), although length of stay in the intensive care unit was shorter (2 days [range 0 to 6 days] vs. 4 days [range 1 to 25 days], p = 0.01). Sixty-seven percent of the RV-PA conduit group had at least one PA intervention 3 years after S1P compared with 42.8% in the modified BTS group (log-rank = 0.11).
CONCLUSIONS: Nonstatistically significant trends toward improved cumulative survival and increased PA interventions were demonstrated in patients who had a RV-PA conduit placed at S1P. Longitudinal follow-up of larger groups of randomized patients is required to determine the influence of the RV-PA conduit on long-term outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18582635     DOI: 10.1016/j.jacc.2008.03.034

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  3 in total

Review 1.  Stem cell therapies in patients with single ventricle physiology.

Authors:  Suguru Tarui; Shunji Sano; Hidemasa Oh
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Apr-Jun

2.  Right ventricle and tricuspid valve function at midterm after the Fontan operation for hypoplastic left heart syndrome: impact of shunt type.

Authors:  Victor Bautista-Hernandez; Mark Scheurer; Ravi Thiagarajan; Joshua Salvin; Frank A Pigula; Sitaram Emani; Francis Fynn-Thompson; Hugo Loyola; Jared Schiff; Pedro J del Nido; Emile A Bacha
Journal:  Pediatr Cardiol       Date:  2010-11-24       Impact factor: 1.655

3.  Living with complex congenital heart disease.

Authors:  Derek G Human
Journal:  Paediatr Child Health       Date:  2009-03       Impact factor: 2.253

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.